A key chapter, provided by bioinformatics firm 3rd Millennium, discusses optimizing microarray experiments. The remainder of the report evaluates the following issues: The pros and cons of protein arrays versus traditional DNA microarrays, How some groups are dealing with complications such as alternative splicing,the advancement of microarrays from pure research applications toward the clinic, new tools and approaches for microarray analysis. The activities of approximately 100 companies are reviewed.